AGP Executive Report
Last update: 3 hours agoEbola Response in Congo: A WHO-sponsored clinical trial has started in eastern Congo to test a monoclonal antibody (MBP134) and an antiviral (remdesivir) against the Bundibugyo Ebola virus, as cases rise to 1,406 with 438 deaths. Rapid Testing Race: A rapid antigen test push has narrowed to five potential manufacturers, aiming for field trials in mid-July to speed up diagnosis and isolation. Conservation Tech: New listening-device work has confirmed African manatees in the Tchimpounga Nature Reserve, with plans for long-term acoustic monitoring and local technician training. Biodiversity & Climate Research: A new study traces how the Congo River’s huge freshwater flow moves into the Atlantic using ocean modeling and satellite/ship data, helping explain plume behavior and eddy transport. Fintech for MSMEs: Optasia says it has launched merchant lending, with deployments planned in Gabon and South Sudan, as Africa’s credit gap pushes more business-focused digital finance. Local Tech/Business: Optasia’s trading update also points to revenue growth expectations across multiple markets, including the Republic of Congo.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
